CheckMyRecalls

Par Health USA, LLC recalls Buprenorphine HCl

Published
24 Jun 2026
Units affected
46,334 units
Agency
FDA
Country
United States

The hazard

Crystallization; identified as Buprenorphine free base

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Buprenorphine HCl, CIII, Injection, 0.3 mg/mL, 5 x 1 mL Single Dose Vials per Carton, Rx Only, For Intramuscular or Intravenous use, Manufactured for: Endo USA, Malvern, PA 19355, NDC 42023-179-05

Brand / company
Par Health USA, LLC
Codes / lots
Lot #: 82886, exp 09/30/2026; 89646, exp 05/31/2027
Distribution
Nationwide in the USA.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 24 Jun 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.